Intarcia’s under skin mini-pump accepted by FDA
Device is first twice-yearly, injection-free exenatide therapy.
X
Intarcia’s under skin mini-pump accepted by FDA
https://pharmaphorum.com/news/intarcias-mini-pump-gets-fda-go-ahead-type-2-diabetes/
Device is first twice-yearly, injection-free exenatide therapy.